Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-19

Clinical Trial Update: Impact of CBD-Rich Oil on Aversive Memory Reconsolidation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating how CBD-rich oil affects aversive memory reconsolidation in anxiety and fear, across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBD-rich oil (cannabidiol-rich oil)

Snippet

Sponsor: University of Texas at Austin | Conditions: Anxiety and Fear | Phase 1, Phase 2 | Status: UNKNOWN